VIR BIOTECHNOLOGY, INC. (VIR) Social Stream
Vir Biotechnology Inc (VIR) Price Targets From Analysts
Use the tables below to see what analysts covering Vir Biotechnology Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 5 | $135 | $37 | $75.6 | $25.33 | 198.46% |
| 2021-11-11 | 5 | $135 | $36 | $75.4 | $25.33 | 197.67% |
| 2021-11-30 | 5 | $200 | $36 | $88.4 | $25.33 | 248.99% |
| 2022-01-31 | 6 | $300 | $36 | $108.4 | $25.33 | 327.95% |
| 2022-02-01 | 6 | $300 | $36 | $96.333 | $25.33 | 280.31% |
| 2022-02-25 | 5 | $300 | $36.001 | $106.4 | $25.33 | 320.06% |
| 2022-03-03 | 6 | $300 | $28 | $93.333 | $25.33 | 268.47% |
| 2022-03-30 | 6 | $200 | $28 | $76 | $25.33 | 200.04% |
The Trend in the Analyst Price Target
Over the past 46 weeks, VIR's average price target has gone down $12.4.
VIR reports an average of 124.09% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-25 | 2 | 135 | 65.000 | 88.400 | 48.91 | 80.74% |
| 2021-09-18 | 7 | 135 | 29.000 | 69.860 | 54.54 | 28.09% |
| 2022-02-01 | 6 | 300 | 36.001 | 108.400 | 35.18 | 208.13% |
| 2022-02-01 | 6 | 300 | 36.000 | 96.333 | 35.18 | 173.83% |
| 2022-03-03 | 6 | 300 | 28.000 | 96.000 | 24.30 | 295.06% |
VIR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 4 | 0 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
VIR's average broker recommendation rating improved by 0.33 over the prior 90 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- VIR has a lower variance in analysts' estimates than -990.49% of all US stocks.
- Vir Biotechnology Inc's upside potential (average analyst target price relative to current price) is greater than 1038.8% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, Vir Biotechnology Inc's average analyst price target is greater than 927.11% of them.
- In the context of stocks in the mid market cap category, Vir Biotechnology Inc's number of analysts covering the stock is greater than 352.97% of them.
Stocks similar to Vir Biotechnology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCEL, TIL, and SWTX.
What is the outlook for VIR? Use POWR Ratings for clearer insight into price direction.